Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Older people tend to have higher biotin levels, which are weakly linked to certain blood components and negatively linked to triglycerides; biotin should be checked in patients with high triglycerides or medication-related skin issues, and only supplemented if deficient. Vitamin D and folate deficiencies are linked to specific skin conditions.

The document concludes that activating hair roots is important for improving hair growth and preventing hair loss.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Alopecia areata is caused by the immune system attacking hair follicles.

People with androgenetic alopecia have more personality disorders and mental health symptoms; treatment may help.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men need higher doses of botox than women and a different approach for facial aesthetics due to their unique facial features and muscle mass.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Hair loss is common in IBD patients, and some medications may lower the risk.

Body hair can be used to test for alcohol intake, especially in men.

Hair and nail cortisol levels can show long-term stress in young males.

Sex hormones may affect COVID-19 severity and outcomes.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

Obesity can cause various skin problems, with differences in prevalence between males and females.

CCCA can affect both genders and all ages, and it has a genetic component.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.